While overlooked compared to viruses and bacteria, fungal diseases are globally on the rise in animals. These diseases can be difficult to diagnosis and treat due to non-distinct symptoms and their ability to evade detection and treatment. To make matters worse, some fungi are capable of overcoming host constraints, allowing them to infect multiple animal species or even humans.

In this post, we will discuss one such fungus, Candida auris. We will explore its host range, impact on animal health, and how early detection and diagnosis can help prevent drug resistance development in this fungus.

Understanding Candida auris

Candida auris (C. auris) is a yeast fungus known for causing the disease, candidiasis in humans and animals. First discovered in 2009, C. auris has emerged as a significant concern in both human and veterinary medicine due to its transmissibility and ability to acquire multiple drug resistances. This fungus poses risks not only to immunocompromised humans but also to various animal species. As veterinarians, understanding its implications is essential for effective management and treatment.

Host Animals: Identifying At-Risk Species

  1. auris has been documented in multiple host species, including domestic cats, dogs, livestock, and even amphibians (Garcia-Bustos, et al., 2024). Immunocompromised animals, particularly those undergoing treatments that suppress their immune systems, are especially susceptible to infection. It is crucial to monitor these populations closely to prevent outbreaks.

Symptoms: Recognizing Clinical Signs

The clinical presentation of C. auris infections can vary among species. Common symptoms include fever, lethargy, and behavioral changes. The disease frequently manifests as a urinary tract infection in cats and dogs (Reagan et al., 2019).  In more severe cases, animals may exhibit skin lesions, respiratory distress, or systemic illness.

Disease Progression: Understanding the Course of Infection

If left untreated, C. auris can progress rapidly, potentially leading to systemic infections that pose serious health risks. Early detection is paramount, as timely intervention can significantly improve outcomes. It is advisable for veterinarians to educate pet owners about the importance of seeking veterinary care at the first sign of illness.

Diagnosis: The Challenge of Accurate Identification

Diagnosing C. auris can be challenging due to its relatively recent emergence and the overlap of symptoms with other conditions. Diagnostic methods typically include fungal cultures, Polymerase Chain Reaction (PCR) testing, and, in some cases, biopsies. However, culture-dependent methods and PCR commonly misdiagnose C. auris as other closely related species (Černáková, et al. 2021). Adoption of Next Generation Sequencing (NGS) technologies can improve diagnosis of C. auris to the species level and help identify antimicrobial resistance mechanisms that strains may possess. Increased awareness and improved testing are critical for accurate diagnosis, allowing for prompt and appropriate treatment.

Treatment Options: Navigating Antifungal Resistance

Antifungal therapy remains the cornerstone of treatment for C. auris infections. However, it is essential to note that resistance to commonly used antifungal agents, such as azoles and echinocandins, has been reported (Du et al., 2020). This resistance complicates treatment options and underscores the necessity for susceptibility testing to guide effective therapeutic strategies. Supportive care, including hydration and nutritional support, is also vital for recovery.

Conclusion: The Importance of Awareness and Vigilance

In summary, Candida auris represents a growing concern in veterinary medicine. By staying informed about its potential impacts, symptoms, and treatment options, veterinarians can play a crucial role in managing this pathogen effectively. Early detection and intervention are essential in safeguarding the health of our animal patients. As we continue to learn about C. auris, collaborative efforts in education and prevention will be vital in addressing this emerging threat.

References

Černáková L, Roudbary M, Brás S, Tafaj S, Rodrigues CF. Candida auris: A Quick Review on Identification, Current Treatments, and Challenges. Int J Mol Sci. 2021 Apr 25;22(9):4470. doi: 10.3390/ijms22094470.

Du H, Bing J, Hu T, Ennis CL, Nobile CJ, Huang G. Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020 Oct 22;16(10):e1008921. doi: 10.1371/journal.ppat.1008921.

Garcia-Bustos V. Is Candida auris the first multidrug-resistant fungal zoonosis emerging from climate change? mBio. 2024 Apr 10;15(4):e0014624. doi: 10.1128/mbio.00146-24.

Reagan KL, Dear JD, Kass PH, Sykes JE. Risk factors for Candida urinary tract infections in dogs and cats. J Vet Intern Med. 2019; 33: 648–653. https://doi.org/10.1111/jvim.15444


Categories: Antimicrobial Resistance, Fungal Infections, Next-Gen DNA Sequencing Technology, Veterinarian Guides

animal diagnostics

Validated by Veterinarians

“Clients expect their veterinarians to stay up to date on all matters that affect the health and well being of their non-human family members. The current technique that we have used to determine the presence and antibiotic sensitivity of organisms causing disease in our pets is over a century old.

With the emergence of dangerous antibacterial resistance, it is critical that veterinarians are able to offer laser focused diagnostics and treatment. MiDog enables us to offer care that exceeds the typical standard of care.”

Bernadine Cruz, DVM, Laguna Hills Animal Hospital Laguna Woods, CA

“I love the absolute abundance and comparing the fungal with bacterial infection. I do not worry as much about getting a false negative urinary infection reading as I do with traditional urine cultures. Several times the same urine would culture negative but MiDOG would detect pathogens.”

Michael Morgan, DVMQuail Animal Hospital, Tustin, CA

“The MiDOG All-in-One Test is amazing, I would use it instead of culture and sensitivity.  Such rapid and detailed results, I will reach for MiDOG before culture next time!

Thank you very much MiDOG, for sharing the opportunity to try your technology.”

Martha Smith-Blackmore, DVM, President of Forensic Veterinary Investigations, LLC – Boston, MA

The MiDOG All-in-One Microbial Test is our new gold standard of pathogen identification. The results are so accurate and valuable – especially with assessing both bacterial and fungal infections with the same sample.

Thank you MiDOG!”

Kathy Wentworth, DVM, Diplomate ABVP Canine and Feline Practice – PetPoint Medical Center, Irvine, CA

“The MiDOG staff was extremely helpful and supportive.”

Cathy Curtis, DVM – London, UK

“I have had great results using the MiDOG® Test. Compared to traditional culture tests, I am better able to target the treatment for dogs because the MiDOG® Test is so sensitive that it identifies all pathogens including bacteria and fungi, as well as antibiotic sensitivity.

The cost and turnaround time are about the same as a culture test, but I get much more data. The test has great performance and I believe the NGS technology will be a game changer for veterinarians treating dogs with lesions or other infections.”

Michael Kavanagh, DVM, Practice owner – Saddleback Animal Hospital, Tustin, CA

“It’s helpful to have an NGS spectrum because it gives you a broader insight of what’s happening and what might be going on.”

Richard Harvey BVSc DVD DipECVD PhD FRSB FRCVS – European Specialist in Veterinary Dermatology – Head of Dermatology, Willows Veterinary Centre & Referral Service – Solihull, England UK

“I have been using MiDog for over 4 years now and exclusively as my test of choice for all cultures for 3 years.  It is so great to submit a culture and feel confident there will be a result when it comes back, especially for urine cultures.  The reports were intimidating at first because they contain so much information.  After the first few, I am now quickly able to glance over it and pick out the highlights.  I can then come back later and pour over all the details.  I have been extremely pleased with my patients’ results using the test as well.  I don’t envision ever going back to traditional culture and susceptibilities again.”

Brian M. Urmson, DVM, Columbiana Veterinary Associates

“As an exotic veterinarian, there are numerous tests we have to consider to check specific bacterial and fungal organisms based on the species. MiDOG eliminates the need for many of these separate samples and provides definitive results quickly to help us treat our patients more efficiently and effectively. The lab is wonderful to work with and has never rejected our samples- they even processed a lizard toe we amputated and determined the cause of skin infection.”

Dr. Melissa Giese, Chicago Exotics Animal Hospital

“MiDOG’s diagnostic approach offers the unique ability to identify pathogens that evade traditional culture and sensitivity testing. I have found that adding a molecular based testing approach in the form of Next Generation Sequencing (NGS) from MiDOG to my routine diagnostic cultures can be extremely helpful in the identification and diagnosis of uncommon pathogens in veterinary medicine.”

Dr. Wayne Rosenkrantz, Animal Dermatology Clinic – Tustin

“She [Dr. Krumbeck] really did a great job of making complicated concepts accessible and demonstrating the value of your services. I’m really looking forward to working with MiDOG on my research project!”

Dr. Yaicha Peters, Animal Dermatology Clinic – San Diego

“As a proud collaborator with MiDOG, I deeply appreciate their dedication to fostering partnerships between industry and veterinary experts. Their commitment to enhancing diagnostic quality for veterinarians is commendable. In my experience, their support has been invaluable, earning them a ‘Double A+, Triple Star’ rating. Their assistance has been faultless, contributing significantly to the success of my projects and studies. I eagerly anticipate our continued collaboration.”

Dr. Richard Harvey, BVSc DVD DipECVD PhD FRSB FRCVS; European Specialist in Veterinary Dermatology

“We’re seeing that, if we prescribe too many antibiotics or they’re taken too frequently, animals are developing inappropriate or pathogenic strains of bacteria. We’re also seeing that our antibiotics are just not working against them anymore… It’s a good example of why we need better diagnostic testing, like MiDOG, so that we’re selecting the correct antibiotic every time our patients have an infection.”

Dr. Alissa Rexo, DVM, CVA, DACVD, Mid-Atlantic Veterinary Dermatology

“The NGS technique as offered by MiDOG is wonderful because pathogens like Melissococcus plutonius, for example, are difficult to grow and keep alive in the laboratory. A standard laboratory cannot truly examine or even properly diagnose this pathogen in bee hives at this time. But with NGS, we can reliably diagnose it.”

Dr. Joerg Mayer, Entomologist and Microbiologist at the University of Georgia

“For me, as a clinician and as a researcher, I see the immense value in the product [the All-in-One Test]. I have had great success using MiDOG clinically, including identifying Mycoplasma in a 24 year old pigeon, a Nannizziopsis spp in a ball python from a large pet distributor, Mycoplasma and Fusobacterium necrophorum co-infection in a peacock, and to identify an abnormal gut GI in a technician’s dog that tested negative for everything else (but we were able to establish what was abnormal, and work toward fixing it).”

Dr. Jeremy Rayl – Veterinarian, Block House Creek Animal Hospital, Cedar Park, Texas

“With MiDog results I not only receive a list of organisms detected in the sample, but also cell counts which allow me to target the most abundant pathogens or the most pathogenic. The identification of antimicrobial resistance genes is also helpful in selecting an appropriate antibiotic. Another benefit is that sample handling is less prone to risk of overgrowth and is stable at room temperature. Easy and informative. A great tool in our diagnostic toolbox!!”

Lauren Palmer DVM, MPH, Marine mammal Care Center Los Angeles